.. particularly back in the first half of the 1990s !
The global money supply was squeezed through the eye of a needle while expansion everywhere constrained .
“The recession we all had to have “ .
Interest rates - even > 20% ! — we paid interest of over 23% also by during 1989 .
The (nominally ex-French- Lederle ) Company was taken over especially for the Production facilities and extensive development site - the vaccine drugs likely , ahead of expanded vaccination globally and compulsory vaccination of children practically everywhere in the world , including eg. Diptheria vaccination .
( developed by the Lederle - American parent company in the 50s . )
Lederle had an extensive emergency drug and overall portfolio - decades of vaccination work , and drug development over the nearly century that the company existed.
In truth Lederle , (the French connection) really was in name only , only residual French company connection- Lederle sold out predominantly to US interests in 1929 when they got into strife by the end of the 1920s . Lederle as a French company only nominally existed therefore.
’Lederle ‘ were beholden to their US- American pharmaceutical Arm , and debt levels had them in strife by the mid 90s.
Lederle had no say in the matter .
Expensive ongoing research and development was dropped with literally the stroke of a pen then .
The seedling ‘Wyeth’ which grew from the acquisition , were not focused in Oncology at all . No interest in continuing Oncology research and development.
Non- oncology and they clearly didn’t see any money in it .
Yes - costs of ongoing phase 3 always an issue - but in the rush and really ruthless rationalisation of assets - Bisantrene didn’t stand a chance .
Bisantrene was already in phase 3 .
*** Bisantrene still is a Phase 3 asset ***
I realise that you know this even more than I do ! @Mer
And you are merely pondering how things go as well .
It is good to see you commenting . I appreciate your long history here and entire knowledge of this journey here in Race .
Thankyou . Let’s hope it can now finally be a good year for Bisantrene and the patients who can truly benefit again . All the best .
General Comments / Chat, page-81
-
- There are more pages in this discussion • 11,148 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.58 |
Change
-0.025(1.56%) |
Mkt cap ! $272.6M |
Open | High | Low | Value | Volume |
$1.69 | $1.69 | $1.55 | $425.8K | 264.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2500 | $1.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.62 | 3588 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 157 | 1.590 |
1 | 2500 | 1.585 |
1 | 5412 | 1.570 |
1 | 1200 | 1.565 |
3 | 3875 | 1.560 |
Price($) | Vol. | No. |
---|---|---|
1.620 | 6088 | 2 |
1.650 | 12582 | 2 |
1.655 | 1069 | 1 |
1.660 | 1602 | 1 |
1.680 | 1830 | 1 |
Last trade - 12.14pm 30/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online